Skip to main content
# Title Department Research Member Research Year
141 Clinicopathological features of relapsed diffuse large B-cell
lymphoma: South Egypt Cancer Institute experience
Department of Biostatistics and Cancer Epidemiology Basma Rezk Farouk Saleh 2021
142 Long term survival outcome of childhood acute lymphoblastic leukemia treated with modified TXIIIB protocol at South Egypt Cancer Institute Department of Pediatric Oncology Dr. Azaa Shibl Sayed Mahmoud 2021
143 Two-bed SPECT/CT versus planar bone scintigraphy: prospective comparison of reproducibility and diagnostic performance Department of Radiotherapy and Nuclear medicine Dr. Yasser Gaber Ali Abdelhafez 2021
144 Higher CD19+ CD25+ Bregs are independently associated with better graft function in renal transplant recipients Department of Clinical Pathology Eman Hosny Mohammed Ibrahim 2021
145 Role of serum miR-21 and miR-92a in colorectal cancer diagnosis as novel molecular biomarkers Department of Surgical Oncology Mohamed Ismail Omar Ali 2021
146 The utility of Multi-Detector Computed Tomography criteria after neoadjuvant therapy in Borderline Resectable Pancreatic cancer: Prospective, bi-institutional study Department of Radiology Dr. Haisam Ahmed Samy Aly Atta 2021
147 Expression of programmed death ligand-1 (PDL-1) in Acute Myeloid Leukemia Patients and its relation to post induction Department of Clinical Pathology Lamyaa Ahmed Abdelhafeez Ahmed 2021
148 Gastric signet ring cell carcinoma, does it confer a worse prognosis and treatment outcome Department of Radiotherapy and Nuclear medicine Dr. Shaimaa / Elsayyed Youssef / Ahmed 2021
149 Bendamustine in Refractory / Relapsed Non Hodgkin Lymphoma Department of Medical Oncology Dr. Maged Abdelfatah Amine Hassan 2021
150 Risk of drug resistance and repeated infection with Klebsiella pneumoniae and Escherichia coli in intensive care unit cancer patients Department of Pediatric Oncology Dr. Ahmed Mohammed Morsy Hassan 2021